IRCT20210310050660N1招募中3 期
Evaluation of Cannabidiol effect as adjunctive therapy on symptoms of patients with Obsessive-Compulsive Disorder
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 55 years（—）
- 性别
- All
入选标准
- •Being healthy
- •Obssesive compulsive disorder (OCD) diagnosis through DSM-5 criteria ( DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS, 5TH EDITION)
- •Achieving at least score 16 according to YALE BROWN OBSSESIVE COMPLUSIVE SCORE ( YBOS)
- •Being only on SSRIs through recent 4 weeks
- •Do not have history of using cannabis or other ilicit drugs
排除标准
- •Unwilling to participate in this study
- •Having history of other psychiatric disorder including psychotic, cognitive and substance use disorder
- •Being medically ill that cause more side effects than usual
- •Pregnancy, expecting to being pregnant and lactation
- •Achieving score more than 17 through completing Beck Depression scale before starting study
研究者
相似试验
进行中（未招募）
1 期
Cannabidiol as an add-on therapy in treatment-refractory psychotic disordersMedDRA version: 16.1Level: HLGTClassification code 10039628Term: Schizophrenia and other psychotic disordersSystem Organ Class: 10037175 - Psychiatric disordersSchizophreniaEUCTR2013-000240-26-GBKing's College London
已完成
2 期
Effect of Non-psychoactive Cannabidiol as an Adjunct to Botulinum Toxin in BlepharospasmBlepharospasmBlepharospasm, Benign EssentialCBDNCT04423341Silkiss Eye Surgery12
招募中
3 期
Evaluation of the effect of cannabidiol in the treatment of dystoniaDystoniaIRCT20211019052811N1Mashhad University of Medical Sciences60
招募中
3 期
Effects of Inclusion of Cannabidiol in the Usual Treatment of Obsessive Compulsive DisorderObsessive-compulsive disorderRBR-467ksmbFaculdade de Medicina de Ribeirão Preto - Universidade de São Paulo
已完成
2 期
Enhancing Medication-based Analgesia in Humans- STUDY 2PainCannabisOpioid UseNCT04036968Johns Hopkins University31